Department of Obstetrics and Gynecology, Firoozgar Clinical Research Development Center, Firoozgar Hospital, Iran University of Medical Sciences, Tehran, Iran.
Department of Obstetrics and Gynecology, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Asian Pac J Cancer Prev. 2024 Feb 1;25(2):661-670. doi: 10.31557/APJCP.2024.25.2.661.
Growing studies revealed the association between polymorphisms in Tumor Protein TP73 (TP73) and susceptibility to cancer, especially with gynecological cancers. but, the results remained inconsistent. This meta-analysis was carried out to examine the relationship of the TP73 G4C14-to-A4T14 polymorphism (hereafter, G4C14-to-A4T14) with susceptibility to cervical cancer globally and by ethnicity.
Eligible studies were collected by retrieving PubMed, Scopus, Web of Science, Embase, Wan Fang, and CNKI published before 25 October, 2023. The pooled odds ratios (ORs) with 95% confidence intervals (CIs) were used to assess the strength of such association.
A total of 10 case-control studies with 1804 cervical cancer cases and 2433 healthy controls were included to this study. The pooled results showed that TP73 G4C14-to-A4T14 polymorphism was not associated with cervical cancer risk in overall. in terms of stratified analyses by ethnicity, this polymorphism was not associated with risk of cervical cancer among East-Asian women. however, there was a significant association based source of control among hospital-based studies.
Inconsistent with previous meta-analyses, our pooled results revealed that TP73 G4C14-to-A4T14 polymorphism might not be a risk factor for development of cervical cancer globally and among East-Asian women. Moreover, further studies examining the effect of gene-gene and gene-environment interactions may eventually provide a better knowledge.
越来越多的研究表明,肿瘤蛋白 TP73(TP73)多态性与癌症易感性之间存在关联,尤其是与妇科癌症。然而,结果仍不一致。本荟萃分析旨在检查 TP73 G4C14 到 A4T14 多态性(以下简称 G4C14 到 A4T14)与全球及按种族宫颈癌易感性的关系。
通过检索 PubMed、Scopus、Web of Science、Embase、万方和中国知网,收集截止到 2023 年 10 月 25 日发表的合格研究。使用合并的优势比(OR)及其 95%置信区间(CI)来评估这种关联的强度。
共有 10 项病例对照研究纳入了 1804 例宫颈癌病例和 2433 例健康对照,用于本研究。汇总结果显示,TP73 G4C14 到 A4T14 多态性与总体宫颈癌风险无关。按种族分层分析,该多态性与东亚女性宫颈癌风险无关。然而,在基于医院的研究中,存在与来源控制有关的显著关联。
与之前的荟萃分析不一致,我们的汇总结果表明,TP73 G4C14 到 A4T14 多态性可能不是全球及东亚女性宫颈癌发展的危险因素。此外,进一步研究检查基因-基因和基因-环境相互作用的影响,可能最终提供更好的知识。